St. Jude Medical (NYSE:STJ) managed to eke out gains of 0.03% in intraday trade. The share price increased by 0.02 points to $76.75. Till last observation, the net money flow was recorded at a negative $(-10.35) million. The total inflow of $11.17 million in upticks was completely overshadowed by an outflow of $21.52 million in downticks, giving the up/down ratio a value of 0.52. The shares have seen a change of -0.78% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $0 million and the composite value in downticks was $11.12 million. The resultant up/down ratio for the block exchange was 0. The block trade had a negative money flow of $(-11.12) million.
St. Jude Medical Inc. has dropped 1.18% in the last five trading days, however, the shares have posted positive gains of 0.12% in the last 4 weeks. St. Jude Medical Inc. is up 40.52% in the last 3-month period. Year-to-Date the stock performance stands at 24.46%.
Currently the company Insiders own 4.8% of St. Jude Medical shares according to the proxy statements. Institutional Investors own 85.37% of St. Jude Medical shares. . On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (VP, Global Quality) of St Jude Medical Inc, Fecho Jeff had sold 10,408 shares worth of $538,198 in a transaction dated February 5, 2016. In this transaction, 10,408 shares were sold at $51.71 per share.
St. Jude Medical (NYSE:STJ) witnessed a decline in the market cap on Friday as its shares dropped 0.38% or 0.29 points. After the session commenced at $76.63, the stock reached the higher end at $76.77 while it hit a low of $76.41. With the volume soaring to 4,530,758 shares, the last trade was called at $76.44. The company has a 52-week high of $80.84. The company has a market cap of $21,730 million and there are 284,277,430 shares in outstanding. The 52-week low of the share price is $48.83.
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).